Clinical trial
A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone…
NCT00253136 · Janssen, LP, Industry · Completed
Key facts
| NCT number | NCT00253136 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia |
| Official title | Risperidone Depot (Microspheres) vs. Placebo in the Treatment of Subjects With Schizophrenia |
| Lead sponsor | Janssen, LP, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | risperidone |
| Enrollment | 458 |
| Start date | Nov 1, 1999 |
| Completion | Dec 1, 2000 |
| First posted | Nov 15, 2005 |
| Last update posted | Dec 3, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: